These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28089149)

  • 61. Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Duran M; Yarlioglues M; Murat SN; Demircelik MB; Ergun G; Acikgoz SK; Sensoy B; Cetin M; Ornek E
    Clin Cardiol; 2014 Aug; 37(8):485-92. PubMed ID: 24805995
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
    Stone GW; Ware JH; Bertrand ME; Lincoff AM; Moses JW; Ohman EM; White HD; Feit F; Colombo A; McLaurin BT; Cox DA; Manoukian SV; Fahy M; Clayton TC; Mehran R; Pocock SJ;
    JAMA; 2007 Dec; 298(21):2497-506. PubMed ID: 18056903
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
    Galli M; Maggioni AP; Vassanelli C; Tavazzi L
    Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N-Terminal Pro-Brain Natriuretic Peptide Level is Associated With Severity and Complexity of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Duran M; Acikgoz SK; Sensoy B; Ergun G; Cetin M; Ornek E
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):69-76. PubMed ID: 24989712
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
    Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F
    Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography.
    Furtado RHM; Nicolau JC; Guo J; Im K; White JA; Sabatine MS; Newby LK; Giugliano RP
    J Am Coll Cardiol; 2020 Jan; 75(3):289-300. PubMed ID: 31976867
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.
    Pan R
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255302
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
    Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW
    Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association study of plasma NT-proBNP levels and severity of acute coronary syndrome.
    Tuxunguli T; Aierken A; Xie X; Dai CF; Yang YN; Li XM; Ma YT
    Genet Mol Res; 2014 Jul; 13(3):5754-7. PubMed ID: 25117333
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
    De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome.
    Kwee LC; Neely ML; Grass E; Gregory SG; Roe MT; Ohman EM; Fox KAA; White HD; Armstrong PW; Bowsman LM; Haas JV; Duffin KL; Chan MY; Shah SH
    Physiol Genomics; 2019 Oct; 51(10):506-515. PubMed ID: 31530226
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 76. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
    Jernberg T; Lindahl B; Siegbahn A; Andren B; Frostfeldt G; Lagerqvist B; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2003 Dec; 42(11):1909-16. PubMed ID: 14662251
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention.
    Peng B; Xia H; Ni A; Wu G; Jiang X
    Herz; 2015 Sep; 40(6):898-905. PubMed ID: 25997425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
    Feldman DN; Wong SC; Bergman G; Minutello RM
    J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The Sisca randomized trial.
    Reuter PG; Rouchy C; Cattan S; Benamer H; Jullien T; Beruben A; Montely JM; Assez N; Raphael V; Hennequin B; Boccara A; Javaud N; Soulat L; Adnet F; Lapostolle F
    Int J Cardiol; 2015 Mar; 182():414-8. PubMed ID: 25596468
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.